Clinical Lung Cancer supports inclusion and diversity

Clinical Lung Cancer is a strong supporter of diversity in science, research and medicine, and is a promoter of inclusion. The journal offers an inclusive and supportive publishing environment and stands against all forms of discrimination, bullying and harassment.

The Editorial Team commits to influencing and improving gender, racial and ethnic diversity and inclusion, and geographic representation in lung cancer research by improving these areas within the journal; e.g. the editorial board, guest editors and authors. This commitment is aligned with Elsevier’s broader ongoing inclusion & diversity efforts. Equity and inclusion in publishing is critically important for scientific excellence and innovation. We believe passionately in the power of an inclusive publishing environment, not only to do what is right, but to enrich, strengthen and advance us all.

Articles in Press

Issue Highlights


Clinical Lung Cancer

Cover Image - Clinical Lung Cancer, Volume 24, Issue 4

Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancerClinical Lung Cancer is devoted to articles on detectiondiagnosisprevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.



Companion Journals

Cover Image - Clinical Breast Cancer, Volume 23, Issue 4
Cover Image - Clinical Genitourinary Cancer, Volume 21, Issue 3
Cover Image - Clinical Colorectal Cancer, Volume 22, Issue 2
Cover Image - Clinical Lymphoma, Myeloma and Leukemia, Volume 23, Issue 6



Impact Factor
5-Year Impact Factor
Eigenfactor Score

Practice Update Oncology News

Attention Qualified Recipients

If you are a qualified recipient of the US print edition of Clinical Lung Cancer, click here to access the online edition.

Most Read (Last 30 Days)

Most Cited (Previous 3 Years)